Frontiers in immunology · 2026
Development of an 8-valent Salmonella and Shigella MAPS vaccine.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Boerth Emily M, Roffler Becky, Hancock Zoe, Gong Joyce, MacLennan Calman A, Zhang Fan, Lu Ying-Jie
Аннотация
INTRODUCTION: Salmonella and Shigella infections are two of the leading causes of global diarrheal deaths in children younger than 5 years. Licensed vaccines against Salmonella Typhi have been shown to be effective, and other Salmonella and Shigella vaccine candidates are being evaluated in clinical trials.
METHODS: We have previously described two 4-valent vaccines against Salmonella and Shigella strains separately. Here, we tested the combination of Salmonella and Shigella vaccines in animal models. ELISA was used to determine antibody titers against antigens, and bactericidal and opsonophagocytic assays were used to determine the function of these antibodies.
RESULTS AND DISCUSSION: We found that the 8-valent Salmonella/Shigella vaccine induced immune responses similar to those of the two 4-valent counterparts. The immunological benefits of the addition of the adjuvant aluminum phosphate (alum), R848/Alum, or AddaS03 were evaluated in rabbits. The results demonstrated that alum augments antibody production against vaccine protein components, and the addition of R848/Alum or AddaS03 significantly enhanced antibody production and bactericidal activity for some serotypes.
METHODS: We have previously described two 4-valent vaccines against Salmonella and Shigella strains separately. Here, we tested the combination of Salmonella and Shigella vaccines in animal models. ELISA was used to determine antibody titers against antigens, and bactericidal and opsonophagocytic assays were used to determine the function of these antibodies.
RESULTS AND DISCUSSION: We found that the 8-valent Salmonella/Shigella vaccine induced immune responses similar to those of the two 4-valent counterparts. The immunological benefits of the addition of the adjuvant aluminum phosphate (alum), R848/Alum, or AddaS03 were evaluated in rabbits. The results demonstrated that alum augments antibody production against vaccine protein components, and the addition of R848/Alum or AddaS03 significantly enhanced antibody production and bactericidal activity for some serotypes.